Search clinical trials for: Poly I:Poly C12U 1250 ug
Total 1229 results
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)Australia
-
National Cancer Institute (NCI)RecruitingLung Neoplasms | Small Cell Lung Cancer | Prostate Cancer | Urothelial Carcinoma | Urothelial CancerUnited States
-
Tango Therapeutics, Inc.TerminatedBreast Cancer | Ovarian Cancer | Prostate Cancer | Pancreas Cancer | BRCA1 Mutation | BRCA-Mutated Ovarian Carcinoma | BRCA-Associated Breast Carcinoma | HRD Positive Advanced Ovarian CancerUnited States
-
BayerGlaxoSmithKlineTerminatedOvarian Cancer | Advanced Solid Tumors (Excluding Prostate Cancer)United States
-
Sheba Medical CenterCompleted
-
Institut BergoniéNational Cancer Institute, FranceCompleted
-
PfizerMedivation, Inc.Completed
-
AstraZenecaParexelApproved for marketing
-
Medical University of South CarolinaTerminated
-
Stemline Therapeutics, Inc.CompletedGlioblastoma Multiforme | Adult Brain GlioblastomaUnited States
-
University of MiamiGlaxoSmithKlineNot yet recruiting
-
Sunnybrook Health Sciences CentreGlaxoSmithKlineRecruitingOvarian Cancer | Stage IV Ovarian Cancer | High Grade Ovarian Serous Adenocarcinoma | Stage III Ovarian CancerCanada
-
Zhejiang Cancer HospitalSun Yat-sen University; Fujian Cancer Hospital; Hunan Cancer Hospital; Zhejiang... and other collaboratorsNot yet recruitingTriple Negative Breast Cancer | Homologous Recombination Deficiency
-
SOLTI Breast Cancer Research GroupRecruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | HER2-negative Breast CancerSpain
-
Ling-Ying WuNot yet recruiting
-
Yonsei UniversityNot yet recruitingTNBC - Triple-Negative Breast CancerKorea, Republic of
-
Tongji HospitalSun Yat-sen University; Qilu Hospital of Shandong University; Hubei Cancer Hospital and other collaboratorsRecruiting
-
Laval UniversityCanadian Institutes of Health Research (CIHR); AstraZenecaRecruiting
-
Spanish Breast Cancer Research GroupAstraZenecaCompleted
-
Dana-Farber Cancer InstituteAstraZenecaWithdrawnUveal Melanoma | Cutaneous Melanoma | Mucosal Melanoma | Recurrent Metastatic MelanomaUnited States
-
AstraZenecaActive, not recruitingOvary CancerFrance, United Kingdom
-
PfizerCompleted
-
Abramson Cancer Center at Penn MedicineTerminatedPancreatic CancerUnited States
-
Memorial Sloan Kettering Cancer CenterClovis Oncology, Inc.Active, not recruiting
-
Wake Forest University Health SciencesEmory UniversityCompletedBrain TumorsUnited States
-
University of Texas Southwestern Medical CenterCompletedBreast Cancer | Ovarian CancerUnited States
-
Hellenic Cooperative Oncology GroupActive, not recruitingOvarian CancerGreece
-
AstraZenecaCompletedRelapsed Ovarian Cancer, BRCA Mutation, Platinum SensitivityUnited States, Canada
-
AstraZenecaCompleted
-
National Cancer Institute (NCI)Active, not recruitingColorectal Adenoma | Colorectal Adenoma With Severe Dysplasia | Colorectal Tubulovillous AdenomaUnited States, Puerto Rico
-
Washington University School of MedicineBristol-Myers SquibbTerminated
-
Tianjin Medical University Cancer Institute and...RecruitingExtensive-stage Small Cell Lung CancerChina
-
Erasmus Medical CenterRecruitingNeuroendocrine Tumors | Peptide Receptor Radionuclide TherapyNetherlands
-
Ruijin HospitalNot yet recruiting
-
Sichuan Cancer Hospital and Research InstituteNot yet recruiting
-
Wuhan UniversityNot yet recruitingRecurrent Small Cell Lung Cancer
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingMetastatic or Locally Advanced Unresectable Solid TumorsUnited States, China, Spain, Japan, United Kingdom
-
AstraZenecaMerck Sharp & Dohme LLC; NRG Oncology; Breast International Group; Myriad Genetic... and other collaboratorsActive, not recruitingBreast CancerUnited States, Austria, Italy, Spain, Sweden, United Kingdom, Belgium, Poland, France, Switzerland, Canada, Germany, Korea, Republic of, Netherlands, Japan, China, Taiwan, Australia, Argentina, Israel, Hungary, Portugal, Iceland, Puerto...
-
University College, LondonAstraZeneca; Cancer Research UKActive, not recruitingHead and Neck CancerUnited Kingdom
-
PfizerCompletedBreast CancerUnited States
-
The University of Hong KongCompletedOvarian CancerHong Kong
-
Dantari, Inc.CompletedHER2-negative Metastatic Breast CancerUnited States
-
Janssen Research & Development, LLCActive, not recruitingProstatic NeoplasmsUnited States, Australia, France, United Kingdom, Belgium, Taiwan, Spain, Israel, Netherlands, Sweden, Korea, Republic of, Canada, Russian Federation, Brazil, Denmark
-
AstraZenecaParexel; Covance; Iqvia Pty Ltd; Theradex; Myriad Genetics, Inc.CompletedNon-Germline BRCA Mutated Ovarian CancerItaly, Spain, Sweden, Canada, Czechia, Poland, United Kingdom, Israel, Austria, Belgium, Switzerland, Netherlands, Bulgaria, Finland, Norway, Denmark, Slovenia, Portugal
-
TakedaCompletedAdvanced Solid TumorsJapan
-
AstraZenecaCompletedLymphoma | Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Malignant Solid TumorsUnited States, Canada
-
Istituto Scientifico Romagnolo per lo Studio e...UnknownNeoplasms, Germ Cell and EmbryonalItaly
-
Peking University Cancer Hospital & InstituteUnknownPancreatic Cancer | Gastric Adenocarcinoma | Cholangiocarcinoma | HER2-negative Breast CancerChina
-
Hunan Cancer HospitalUnknown
-
AstraZenecaCompletedCancer | Advanced Solid MalignanciesJapan